Literature DB >> 19602565

Breast carcinoma--rare types: review of the literature.

R Yerushalmi1, M M Hayes, K A Gelmon.   

Abstract

Invasive breast cancer is a heterogeneous disease in its presentation, pathological classification and clinical course. However, there are more than a dozen variants which are less common but still very well defined by the World Health Organization (WHO) classification. The rarity of many of these neoplasms does not allow large or randomized studies to define the optimal treatment. Many of the descriptions of these cancers are from case reports and small series. Our review brings updated information on 16 epithelial subtypes as classified by the WHO system with a very concise histopathology description and parameters helpful in the clinic. The aim of our review is to provide a tool for breast cancer caregivers which will enable a better understanding of the disease and its optimal approach to therapy. This may also stand as a clinical framework for a future understanding of these rarer breast cancers when gene analysis work is reported.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19602565     DOI: 10.1093/annonc/mdp245

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  54 in total

Review 1.  Histological types of breast cancer: how special are they?

Authors:  Britta Weigelt; Felipe C Geyer; Jorge S Reis-Filho
Journal:  Mol Oncol       Date:  2010-04-18       Impact factor: 6.603

2.  Mucinous breast carcinoma with tall columnar cells.

Authors:  N Tsoukalas; M Kiakou; M Tolia; I D Kostakis; M Galanopoulos; G Nakos; D Tryfonopoulos; G Kyrgias; G Koumakis
Journal:  Ann R Coll Surg Engl       Date:  2018-04-16       Impact factor: 1.891

Review 3.  Rare breast tumors: Review of the literature.

Authors:  Catalina Acevedo; Claudia Amaya; Jose-Luis López-Guerra
Journal:  Rep Pract Oncol Radiother       Date:  2013-09-27

4.  Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.

Authors:  Sofia Levva; Vassiliki Kotoula; Ioannis Kostopoulos; Kyriaki Manousou; Christos Papadimitriou; Kyriaki Papadopoulou; Sotiris Lakis; Kyriakos Koukoulias; Vasilios Karavasilis; George Pentheroudakis; Eufemia Balassi; Flora Zagouri; Ioannis G Kaklamanos; Dimitrios Pectasides; Evangelia Razis; Gerasimos Aravantinos; Pavlos Papakostas; Dimitrios Bafaloukos; Grigorios Rallis; Helen Gogas; George Fountzilas
Journal:  Cancer Genomics Proteomics       Date:  2017 May-Jun       Impact factor: 4.069

5.  Co-expression of EGFR and CK5/6 in primary squamous cell carcinoma of the breast.

Authors:  Jin Wang; Xinke Zhang; Jiehua He; Mingtian Yang; Jun Tang; Xing Li; Hailin Tang; Xiaoming Xie
Journal:  Med Oncol       Date:  2014-08-15       Impact factor: 3.064

6.  Resistance to trastuzumab in HER2-positive mucinous invasive ductal breast carcinoma.

Authors:  Zora Baretta; Rodrigo Santa Cruz Guindalini; Galina Khramtsova; Olufunmilayo I Olopade
Journal:  Clin Breast Cancer       Date:  2012-12-29       Impact factor: 3.225

7.  Residual mucin and response after neoadjuvant chemotherapy (NAC) in breast cancer.

Authors:  Maria Jove; Eldo Verghese; Nisha Sharma; Sally Lane
Journal:  BMJ Case Rep       Date:  2016-05-06

8.  Unusual Breast Neoplasm with Diagnostic and Management Challenges.

Authors:  Chanchal Rana; Pooja Ramakant; Suresh Babu; Kulranjan Singh; Anand Mishra; Sasi Mouli
Journal:  Indian J Surg Oncol       Date:  2018-05-24

9.  Targeting the PyMT Oncogene to Diverse Mammary Cell Populations Enhances Tumor Heterogeneity and Generates Rare Breast Cancer Subtypes.

Authors:  Brittni A Smith; Dawne N Shelton; Collin Kieffer; Brett Milash; Jerry Usary; Charles M Perou; Philip S Bernard; Bryan E Welm
Journal:  Genes Cancer       Date:  2012-09

10.  Rare breast cancer subtypes: histological, molecular, and clinical peculiarities.

Authors:  Maria Vittoria Dieci; Enrico Orvieto; Massimo Dominici; PierFranco Conte; Valentina Guarneri
Journal:  Oncologist       Date:  2014-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.